These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3265675)

  • 21. Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.
    Wan Y; Xue X; Li M; Zhang X; Qin X; Zhang C; You Y; Wang W; Jiang C; Wu S; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    Cell Immunol; 2007 Apr; 246(2):55-64. PubMed ID: 17592730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation.
    Coral S; Pucillo C; Leonardi A; Fonsatti E; Altomonte M; Maio M
    Cell Growth Differ; 1997 May; 8(5):581-8. PubMed ID: 9149909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model.
    Jaeschke H; Fisher MA; Lawson JA; Simmons CA; Farhood A; Jones DA
    J Immunol; 1998 Apr; 160(7):3480-6. PubMed ID: 9531309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment.
    Anderson MR; Tary-Lehmann M
    Clin Immunol; 2001 Jan; 98(1):85-94. PubMed ID: 11141330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic antibodies elicited by immunization against TNF-alpha.
    Dalum I; Butler DM; Jensen MR; Hindersson P; Steinaa L; Waterston AM; Grell SN; Feldmann M; Elsner HI; Mouritsen S
    Nat Biotechnol; 1999 Jul; 17(7):666-9. PubMed ID: 10404159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions.
    McKenzie JL; Calder VL; Starling GC; Hart DN
    Bone Marrow Transplant; 1995 Feb; 15(2):163-71. PubMed ID: 7773205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor alpha regulation of immunoglobulin secretion in trauma patients.
    Teodorczyk-Injeyan JA; Cembrzynska-Nowak M; Lalani S; Rizoli S; Taylor G
    Circ Shock; 1994 May; 43(1):26-33. PubMed ID: 7982270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell mediated lethal shock induced by bacterial superantigens.
    Wagner H; Heeg K; Miethke T
    Behring Inst Mitt; 1992 Apr; (91):46-53. PubMed ID: 1524570
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunomodulation by bacterial endotoxin.
    Burrell R
    Crit Rev Microbiol; 1990; 17(3):189-208. PubMed ID: 1689164
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibody to TNFalpha in septic shock.
    Cohen J
    Lancet; 1998 Jun; 351(9117):1731. PubMed ID: 9734908
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interleukin-7, a new immunoadjuvant for the treatment of septic shock].
    Monneret G; Villars-Méchin A; Demaret J; Foray AP; Venet F
    Med Sci (Paris); 2014 Feb; 30(2):160-5. PubMed ID: 24572114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory effect of tumor necrosis factor.
    Bonavida B
    Biotherapy; 1991; 3(2):127-33. PubMed ID: 2054253
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tumor necrosis factor (TNF)].
    Watanabe N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():767-70. PubMed ID: 8753354
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumour necrosis factor and septic shock.
    Waage A
    Lancet; 1998 Feb; 351(9102):603. PubMed ID: 9492815
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor necrosis factor in septic shock and multiple system trauma.
    Dellinger RP
    Crit Care Med; 1997 Nov; 25(11):1771-3. PubMed ID: 9366750
    [No Abstract]   [Full Text] [Related]  

  • 36. A proinflammatory mediator with potential relevance in aging.
    Beutler B
    J Am Geriatr Soc; 1990 Sep; 38(9):1027-36. PubMed ID: 2212439
    [No Abstract]   [Full Text] [Related]  

  • 37. Modalities of experimental TNF blockade in vivo: mouse models.
    Kruglov AA; Tumanov AV; Grivennikov SI; Shebzukhov YV; Kuchmiy AA; Efimov GA; Drutskaya MS; Scheller J; Kuprash DV; Nedospasov SA
    Adv Exp Med Biol; 2011; 691():421-31. PubMed ID: 21153347
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunomodulation: a new approach to the therapy of cirrhosis?
    Marra F; Annunziato F
    Gut; 2010 Jul; 59(7):868-9. PubMed ID: 20581231
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic factors in septic shock.
    Kumar A; Short J; Parrillo JE
    JAMA; 1999 Aug; 282(6):579-81. PubMed ID: 10450722
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibody to TNF in severe septic shock.
    Exley AR; Cohen J; Buurman W; Owen R; Hanson G; Lumley J; Aulakh JM; Bodmer M; Riddell A; Stephens S
    Lancet; 1990 May; 335(8700):1275-7. PubMed ID: 1971339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.